Noteworthy Stock to Watch For: Henry Schein, Inc. (HSIC)

14 analysts on average are expecting Henry Schein, report earnings of $0.98 per share for the current quarter. (NASDAQ:HSIC) in a report published on Thursday morning. Henry Schein has a 12-month low of $142.64 and a 12-month high of $183.00. Virginia Retirement Systems ET AL bolstered its holdings by buying 171,000 shares an increase of 111.5% in the quarter. The return on assets stands at 7.9%, Return on Equity now is 19.2% and the Return on Investment value is 13.8%. BlackRock Fund Advisors increased its position in Henry Schein by 2.4% in the second quarter.

Whereas for long term intention, measuring performance with long timeframe can help for taking more accurate investment decision that includes quarter, semi-annual and annual performance. Trust Co. of Vermont lifted its stake in Henry Schein by 56.7% during the third quarter. The earnings per share growth over the next five years are expected to be 9.77%. National Pension Service lifted its stake in shares of Henry Schein by 9.6% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company's stock worth $104,000 after purchasing an additional 28 shares in the last quarter. Finally, Lee Financial Co boosted its stake in shares of Henry Schein by 100.0% in the 3rd quarter. The firm's revenue for the quarter was up 10.3% compared to the same quarter last year. equities analysts predict that Henry Schein, Inc. will post 3.6 earnings per share for the current year. Institutional ownership in the company is 92.60% while the short ratio is 5.49. Goldman Sachs Group Inc. raised Henry Schein from a neutral rating to a buy rating and set a $185.00 price objective for the company in a research note on Tuesday, October 11th. (NASDAQ:HSIC) Performing Well?

Xcel Energy Inc. (NYSE:XEL) posting a 1.18% after which it closed the day' session at $50.79 and the company has experienced volume of 3,419,279 shares while on average the company has a capacity of trading 2.70M share while its relative trading volume is 1.26. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The company has a market cap of $10,730.00, a P/E ratio of 19.64, a P/E/G ratio of 1.90 and a beta of 1.03. As a result, the company has an EPS growth of 8.59% for the approaching year. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The business had revenue of $3.16 billion during the quarter, compared to analysts' expectations of $3.05 billion. According to their observations and findings, the stock could provide a high EPS of $1.01/share and a low EPS of $0.97/share. The business's quarterly revenue was up 6.7% compared to the same quarter a year ago. This repurchase authorization permits the company to repurchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its stock is undervalued.

In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the stock in a transaction that occurred on Wednesday, September 6th. Following the sale, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Week Herald and is the property of of Week Herald. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of USA and worldwide copyright & trademark legislation.

"Penserra Capital Management LLC Buys 2,178 Shares of Henry Schein, Inc".

HSIC has been the topic of several analyst reports. Zacks Investment Research lowered Henry Schein from a hold rating to a sell rating in a research note on Tuesday, September 20th. UBS AG reiterated a "buy" rating on shares of Henry Schein in a research note on Friday, September 15th. The count of Hold ratings in that period was 0. Finally, TheStreet downgraded Henry Schein from a "b" rating to a "c+" rating in a research note on Monday, November 6th. Reagents Global Market (Hot stocks In Focus) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. The company has a consensus rating of Hold and a consensus price target of $159.77.

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment fix services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.